Table I.

EC50s for EBV-positive and EBV-negative B cell lines treated with ganetespib.

	EC50 (nM)*	SD	EBV Latency State
LCLa	22.5	0.50	3
LCLb	19.5	1.5	3
BJAB	22.5	2.5	EBV negative
BL30	25.5	1.5	EBV negative
Akata	25.5	1.5	1
Kem1	37	2.0	1
Mutu I	26	4.0	1
SNT16	41.3	1.4	2
Jurkat	29.3	3.6	EBV-negative

^*EC50 is the effective concentration at which 50% of the cells were killed. Each value for the cells in the first seven rows represents the average of two experiments that were performed in triplicate, and for the last two rows each value is the average of three experiments; SD is the standard deviation of the data.